Skip to content

Once-daily boosted saquinavir has low blood levels when used with key anti-TB drug

HIV treatment targets cannot be met without both big pharmaceuticals and Chinese, says WHO official

New syphilis cases and resistant gonorrhoea increase in US gay men

Fluconazole prophylaxis: resistance risk lower than fungal disease risk

International HIV community conference cancelled due to lack of funding

Low-dose ritonavir almost entirely responsible for lipid increases seen on Kaletra

Study examines role of AZT and d4T in metabolic changes

Schistosomiasis treatment improves CD4 count, viral load in HIV-positives

Some groups get more benefit from anti-HIV drugs than others